SpyGlass Pharma SGP
NASDAQ SGP
$34.52 +0.34 (+0.99%)
As of: Nov 11, 2026 · 9:53 AM EST

SpyGlass Pharma (SGP) Return on Assets [ROA] (2026)

Updated

SpyGlass Pharma (SGP) recorded Return on Assets [ROA] of -57.29% in FY2025.

Analysis

SpyGlass Pharma (SGP) Return on Assets [ROA] (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 SpyGlass Pharma 1.14 Bn 534.30 Mn - -20.40%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.40%
API Access

SpyGlass Pharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SGP&period=max&api_key=YOUR_API_KEY